Zuellig Pharma Acquires Propan Brand in the Philippines
The acquisition of Propan enhances Zuellig Pharma's presence in the Philippine consumer health market, a significant segment within Southeast Asia.
Acquired Propan, a leading multivitamin-appetite stimulant brand, in the Philippines.
Zuellig Pharma has completed the acquisition of Propan, a leading multivitamin and appetite stimulant brand in the Philippines. This acquisition strengthens Zuellig Pharma's consumer health portfolio in the country, aiming to leverage the brand's established market position to further expand its reach and offerings in the Philippine healthcare landscape.
The acquisition of Propan enhances Zuellig Pharma's presence in the Philippine consumer health market, a significant segment within Southeast Asia. By integrating a well-established brand known for its efficacy in multivitamins and appetite stimulation, the company can cater to a broader consumer base and strengthen its competitive position in a key APAC market.
This acquisition directly impacts the Philippine consumer health market, strengthening Zuellig Pharma's portfolio with a popular local brand.
Where this signal fits in the broader landscape.
Zuellig Pharma Acquires Zam-Buk and Vapex Brands from Bayer
Zuellig Pharma Expands Lundbeck Partnership for Neuro-Psychiatric Solutions
Zuellig Pharma Opens Clinical Trial Support Innovation Center in South Korea
Zuellig Pharma Opens Clinical Trial Support Center in South Korea
Zuellig Pharma Launches Lilly's Obesity and Diabetes Medicine in Thailand
https://www.zuelligpharma.com/news-insights/zuellig-pharma-acquires-propan-from-adp-pharma-corporation-in-the-philippines
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
로그인